Fortress Biotech, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Fortress Biotech, Inc. (FBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 540.00 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-31
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 540.00K shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 540.00K shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 133.50K shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 35.00K shares, a 86.38% decline from fiscal 2020.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 257.01K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-31 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-31 | 540.00K shares 10-K · filed 2026-03-31 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-14 | 540.00K shares 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 540.00K shares 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 540.00K shares 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | 133.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 131.00K shares derived: sum of 2 quarters · filed 2024-03-28 | 131.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 133.50K shares 10-K · filed 2024-03-28 | |
| 2023-09-30 | -2.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -2.33K shares derived: sum of 2 quarters · filed 2023-11-14 | 166.00 shares 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 2.50K shares 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 2.50K shares 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 10.00K shares derived: sum of 2 quarters · filed 2023-03-31 | 10.00K shares derived: sum of 3 quarters · filed 2023-03-31 | 35.00K shares 10-K · filed 2023-03-31 | |
| 2021-09-30 | 10.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 10.00K shares derived: sum of 2 quarters · filed 2021-11-15 | 35.00K shares 10-Q · filed 2021-11-15 | 45.00K shares derived: sum of 4 quarters · filed 2022-03-28 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 25.00K shares 10-Q · filed 2021-08-16 | 35.00K shares derived: sum of 3 quarters · filed 2022-03-28 | ||
| 2021-03-31 | 25.00K shares 10-Q · filed 2021-05-17 | 35.00K shares derived: sum of 2 quarters · filed 2022-03-28 | |||
| 2020-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 257.01K shares 10-K · filed 2022-03-28 | |||
| 2020-09-30 | 247.01K shares 10-Q · filed 2020-11-09 | ||||
| 2018-12-31 | 25.00K shares 10-K · filed 2020-03-16 | ||||
| 2017-12-31 | 25.00K shares 10-K · filed 2019-03-18 | ||||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 623.86K shares derived: sum of 2 quarters · filed 2018-03-16 | 648.86K shares 10-K · filed 2018-03-16 | -648.86K shares 10-K · filed 2017-03-16 | |
| 2016-09-30 | 623.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 648.86K shares 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | 25.00K shares 10-Q · filed 2016-08-09 | ||||
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 285.00K shares derived: sum of 2 quarters · filed 2016-03-15 | 285.00K shares derived: sum of 3 quarters · filed 2016-03-15 | 285.00K shares 10-K · filed 2016-03-15 | |
| 2015-09-30 | 285.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 285.00K shares derived: sum of 2 quarters · filed 2015-11-09 | 285.00K shares 10-Q · filed 2015-11-09 | -629.09M shares derived: sum of 4 quarters · filed 2015-11-09 | |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 0.00 shares 10-Q · filed 2015-08-10 | -629.37M shares derived: sum of 3 quarters · filed 2015-08-10 | -629.37M shares derived: sum of 4 quarters · filed 2015-08-10 | |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-11 | -629.37M shares derived: sum of 2 quarters · filed 2015-05-11 | -629.37M shares derived: sum of 3 quarters · filed 2015-05-11 | 600.63M shares derived: sum of 4 quarters · filed 2015-05-11 | |
| 2014-12-31 | -629.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -629.37M shares derived: sum of 2 quarters · filed 2015-03-16 | 600.63M shares derived: sum of 3 quarters · filed 2015-03-16 | 630.00K shares 10-K · filed 2015-03-16 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 1.23B shares derived: sum of 2 quarters · filed 2014-11-06 | 630.00M shares 10-Q · filed 2014-11-06 | ||
| 2014-06-30 | 1.23B shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 630.00M shares 10-Q · filed 2014-08-11 | |||
| 2014-03-31 | -600.00M shares 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | -1.32M shares 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |